Kinase inhibitors for the treatment of diabetes and obesity

Details for Australian Patent Application No. 2012208983 (hide)

Owner Odyssey Thera, Inc

Inventors Westwick, John K.; Lamerdin, Jane; Owens, Stephen; MacDonald, Marnie L.

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-A-2012208983

Parent 2005299572

Filing date 20 July 2012

Wipo publication date 16 August 2012

International Classifications

C07D 279/12 Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

16 August 2012 Application Open to Public Inspection

  Published as AU-A-2012208983

16 August 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012208984-Screen panel fixing system

2012208982-Suppressant actuator